Sarepta Archives - Pharmaphorum

ICER posts damning report on Sarepta’s Duchenne drug Exondys 51

https://pharmaphorum.com/news/icer-posts-damning-report-on-sareptas-duchenne-drug-exondys-51/

Sarepta DMD gene therapy could improve patients’ motor function

https://pharmaphorum.com/news/sarepta-dmd-gene-therapy-could-improve-patients-motor-function/

Sarepta dives deeper into gene therapy

https://pharmaphorum.com/news/sarepta-dives-deeper-gene-therapy/

Summit shares plunge nearly 80% after DMD drug fails

https://pharmaphorum.com/news/summit-shares-plunge-dmd-drug-fail/

Pharma collaborates to improve chances of NICE backing Duchenne drugs

https://pharmaphorum.com/news/pharmas-join-improve-duchenne-muscular-dystrophy/

Contrasting fortunes for Duchenne rivals, as PTC fails and Sarepta soars

https://pharmaphorum.com/news/contrasting-fortunes-duchennes-rivals-ptc-fails-sarepta-soars/

PTC Therapeutics fails to convince FDA panel about DMD drug

https://pharmaphorum.com/news/ptc-therapeutics-fails-convince-fda-panel-dmd-drug/

FDA reviewers slam PTC’s Duchenne drug ahead of meeting

https://pharmaphorum.com/news/fda-reviewers-slam-ptc-dmd-drug-ahead-key-meeting/

EU regulators reject Santhera’s Raxone for DMD

https://pharmaphorum.com/news/eu-regulators-reject-santheras-raxone-dmd/

Search